|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3334763 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16834675.7 |
| Date of filing the European patent application | 2016-08-11 | |
| (97) | Date of publication of the European application | 2018-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2024-08-07 |
| (46) | Date of publication of the claims translation | 2025-01-10 |
| (86) | Number | PCT/CN2016/094624 |
| Date | 2016-08-11 |
| (87) | Number | WO 2017/025051 |
| Date | 2017-02-16 |
| (30) | Number | Date | Country code |
| PCT/CN2015/086594 | 2015-08-11 | WO | |
| PCT/CN2016/071374 | 2016-01-19 | WO |
| (72) |
ZHENG, Yong , CN
LI, Jing , US
CHEN, Zhisheng , CN
|
| (73) |
WuXi Biologics Ireland Limited ,
One Spencer Dock
North Wall Quay, Dublin 1,
IE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nauji anti-PD-1 antikūnai |
| NOVEL ANTI-PD-1 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 10 | 231.00 EUR |
| 2026-08-11 |